- Anti-inflammatory Properties of High-density Lipoprotein cholesterol in Chronic Hemodialysis Patients: Impact of Intervention2010 | Faculty of Medicine in Hradec Králové, Faculty of Physical Education and Sport
- Inclisiran, Low-Density Lipoprotein Cholesterol and Lipoprotein (a)2023 | First Faculty of Medicine
- Blood pressure and low-density lipoprotein-cholesterol lowering for prevention of strokes and cognitive decline: a review of available trial evidence2014 | First Faculty of Medicine
- Low prevalence of type 2 diabetes mellitus among patients with high levels of high-density lipoprotein cholesterol2013 | First Faculty of Medicine
- Comparison of Low-Density Lipoprotein Cholesterol Assessment by Martin/Hopkins Estimation, Friedewald Estimation, and Preparative Ultracentrifugation: Insights From the FOURIER Trial2018 | First Faculty of Medicine
- Anti-inflammatory Properties of High-density Lipoprotein Cholesterol in Chronic Hemodialysis Patients: Impact of Intervention2010 | First Faculty of Medicine
- Evolocumab for the treatment of familial hypercholesterolemia2017 | Faculty of Medicine in Hradec Králové
- Pharmacological treatment of severe dyslipidaemia in patients with schizophrenia +12007 | Faculty of Medicine in Hradec Králové
- In patients with stable coronary heart disease, low-density lipoprotein-cholesterol levels < 70 mg/dL and glycosylated hemoglobin A1c < 7% are associated with lower major cardiovascular events2020 | Publication without faculty affiliation
- The role of PCSK9-inhibitors and of lipoprotein apheresis in the treatment of homozygous and severe heterozygous familial hypercholesterolemia: A rivalry, or are things quite different?2018 | Faculty of Medicine in Hradec Králové
- Relationships between common polymorphisms of adenosine triphosphate-binding cassette transporter Al and high-density lipoprotein cholesterol and coronary heart disease in a population with type 2 diabetes mellitus2009 | Second Faculty of Medicine
- Clinical Management of High and Very High Risk Patients with Hyperlipidaemia in Central and Eastern Europe: An Observational Study2019 | First Faculty of Medicine
- Dynamics of blood count after rheohemapheresis in age-related macular degeneration: Possible association with clinical changes2014 | Faculty of Medicine in Hradec Králové
- Lipid-lowering therapy use in primary and secondary care in Central and Eastern Europe: DA VINCI observational study2021 | First Faculty of Medicine
- Role of lomitapide in treatment of severe familial hypercholesterolaemia2020 | Faculty of Medicine in Hradec Králové
- Protective associations of HDL with blood-brain barrier injury in multiple sclerosis patients2015 | First Faculty of Medicine
- Blood pressure and LDL-cholesterol targets for prevention of recurrent strokes and cognitive decline in the hypertensive patient: design of the European Society of Hypertension-Chinese Hypertension League Stroke in Hypertension Optimal Treatment randomized trial2014 | First Faculty of Medicine
- Combined hypolipidemic therapy using statins and fibrates reducing the cardiovascular risk in the patients with atherogenic dyslipidemia2010 | Faculty of Medicine in Hradec Králové
- Residual vascular risk in diabetes - Will the SPPARM alpha concept hold the key?Publication without faculty affiliation
- Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome2020 | Publication without faculty affiliation
- Blood pressure control and risk profile in poststroke survivors: a comparison with the general population2015 | Faculty of Physical Education and Sport, First Faculty of Medicine, Faculty of Medicine in Pilsen
- Time Trends in Lifestyle, Risk Factor Control, and Use of Evidence-Based Medications in Patients With Coronary Heart Disease in Europe Results From 3 EUROASPIRE Surveys, 1999-20132017 | First Faculty of Medicine
- Repositioning of the global epicentre of non-optimal cholesterol2020 | First Faculty of Medicine
- Trends in Prevalence of Dyslipidaemias and the Risk of Mortality in Lithuanian Urban Population Aged 45-64 in Relation to the Presence of the Dyslipidaemias and the Other Cardiovascular Risk Factors2014 | Central Library of Charles University
- A 52-Week Placebo-Controlled Trial of Evolocumab in Hyperlipidemia2014 | First Faculty of Medicine
- Efficacy and Safety of K-877 (Pemafibrate), a Selective PPARα Modulator, in European Patients on Statin Therapy2022 | First Faculty of Medicine
- Komentář k článku: Léčba hypercholesterolemie v primární prevenci2019 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Metabolic syndrome - diagnostics and therapy2010 | Faculty of Medicine in Hradec Králové, Faculty of Physical Education and Sport, First Faculty of Medicine, Faculty of Medicine in Pilsen
- The association between lipid parameters and obesity in university students2016 | Faculty of Medicine in Pilsen